X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5625) 5625
Book Review (1524) 1524
Publication (658) 658
Book Chapter (28) 28
Conference Proceeding (16) 16
Dissertation (4) 4
Magazine Article (4) 4
Government Document (3) 3
Book / eBook (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5188) 5188
humans (5030) 5030
female (3104) 3104
oncology (2785) 2785
receptor, erbb-2 - antagonists & inhibitors (2121) 2121
receptor, erbb-2 - metabolism (1976) 1976
animals (1916) 1916
breast cancer (1784) 1784
breast neoplasms - drug therapy (1651) 1651
cell line, tumor (1459) 1459
cancer (1445) 1445
breast neoplasms - pathology (1239) 1239
trastuzumab (1196) 1196
breast neoplasms - metabolism (1174) 1174
mice (1156) 1156
antineoplastic agents - therapeutic use (1014) 1014
receptor, erbb-2 - genetics (1010) 1010
antineoplastic agents - pharmacology (974) 974
receptor, epidermal growth factor - antagonists & inhibitors (949) 949
expression (849) 849
signal transduction (842) 842
growth-factor receptor (785) 785
middle aged (766) 766
breast neoplasms - genetics (735) 735
chemotherapy (703) 703
research (691) 691
epidermal growth factor (676) 676
her2 (673) 673
biochemistry & molecular biology (662) 662
signal transduction - drug effects (658) 658
receptor, epidermal growth factor - metabolism (651) 651
tumors (648) 648
care and treatment (632) 632
cell biology (630) 630
aged (617) 617
phosphorylation (616) 616
male (609) 609
adult (601) 601
cell proliferation - drug effects (594) 594
breast-cancer (578) 578
skin and connective tissue diseases (575) 575
apoptosis (570) 570
therapy (549) 549
health aspects (527) 527
metastasis (521) 521
antibodies, monoclonal, humanized (519) 519
proteins (513) 513
egfr (509) 509
prognosis (488) 488
gene expression (487) 487
antineoplastic combined chemotherapy protocols - therapeutic use (484) 484
kinases (480) 480
medicine & public health (477) 477
protein kinase inhibitors - pharmacology (476) 476
analysis (471) 471
article (471) 471
quinazolines - pharmacology (468) 468
treatment outcome (463) 463
drug resistance, neoplasm (458) 458
antibodies, monoclonal - therapeutic use (457) 457
erbb-2 protein (448) 448
monoclonal-antibody (442) 442
apoptosis - drug effects (433) 433
activation (429) 429
xenograft model antitumor assays (421) 421
pharmacology & pharmacy (420) 420
protein kinase inhibitors - therapeutic use (413) 413
mutation (408) 408
tumor cells, cultured (408) 408
genetic aspects (407) 407
tyrosine kinase inhibitor (406) 406
gene expression regulation, neoplastic (395) 395
growth (394) 394
cells (393) 393
immunohistochemistry (384) 384
research article (378) 378
mice, nude (373) 373
receptors, estrogen - metabolism (371) 371
molecular targeted therapy (364) 364
lapatinib (352) 352
receptor, epidermal growth factor - genetics (339) 339
epidermal-growth-factor (336) 336
quinazolines - therapeutic use (335) 335
antibodies, monoclonal - pharmacology (333) 333
resistance (332) 332
receptor (331) 331
tyrosine (328) 328
medicine (326) 326
neoplasms - drug therapy (325) 325
development and progression (319) 319
survival (318) 318
ligands (311) 311
cancer therapies (308) 308
cell proliferation (304) 304
drug therapy (302) 302
cancer research (298) 298
estrogen (297) 297
cell lung-cancer (295) 295
in-vivo (294) 294
multidisciplinary sciences (289) 289
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5532) 5532
French (56) 56
German (17) 17
Chinese (12) 12
Japanese (12) 12
Russian (6) 6
Spanish (3) 3
Hungarian (2) 2
Polish (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncogene, ISSN 0950-9232, 08/2008, Volume 27, Issue 37, pp. 5019 - 5032
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7691, pp. 189 - 194
Journal Article
Annals of Oncology, ISSN 0923-7534, 2013, Volume 24, Issue 9, pp. 2206 - 2223
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 12/2010, Volume 30, Issue 23, pp. 5456 - 5472
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | ERBB2 | INHIBITOR | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Medical research | Ligands | Cytotoxicity | Mammography | Kinases | Cancer therapies | Index Medicus | Abridged Index Medicus | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Surgery | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | Diarrhea | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2011, Volume 29, Issue 4, pp. 398 - 405
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 461 - 471
Journal Article